Jul 29, 2020 - Intel fires its Indian-origin chief engineer Murthy Renduchintala for production failures

TradeBriefs Newsletter
View online   Advertise
              from India Software

TradeBriefs Editorial

From the Editor's Desk

'We Will Share Our Vaccine with the World.' Inside the Chinese Biotech Firm Leading the Fight Against COVID-19

During the 2002 to 2003 SARS outbreak, which claimed over 774 lives worldwide, Chinese biotech company SinoVac was the only firm to go into phase 1 vaccine trials, but the pandemic suddenly disappeared. That meant that research was discontinued at a huge loss for the firm. It wasn't entirely wasted, however. Now, 17 years later, SinoVac is able to build on that earlier work, given that COVID-19 is very similar to SARS. It and coronavirus are "like brothers," says Yin Weidong, the CEO of SinoVac.

In principle, SinoVac is a private company that owns CoronaVac as its licensed intellectual property, meaning where the vaccine is distributed should be a purely commercial decision. However, the Chinese government has contributed to the estimated one billion renminbi (about $140 million) the firm is investing in CoronaVac. This and other contributions from international NGOs currently under negotiation all come with distribution commitments attached.

In a speech to the World Health Assembly on May 18, Chinese President Xi Jinping promised to make a COVID-19 vaccine produced in China a "global public good." In reality, of course, every queue has someone at the back, meaning there will be much jostling for priority - and potentially boosting Beijing's global clout.

Continued here

TradeBriefs: What's important, not just what's popular!

Advertisers of the day

IIT Bombay-WashU Executive MBA (Batch 6): 17 classroom immersions | 15+ session topics | Drive results for your organization| Apply now!

Our advertisers help fund the daily operations of TradeBriefs. We request you to accept our promotional emails.

Apps that Facebook copied before taking on TikTok with Reels

Facebook CEO Mark Zuckerberg has always believed in a simple formula: If you want to beat your rivals, either acquire them or copy them in such a way ..

Today's TradeBriefs Cartoon

Infy looking at buys ‘that make sense’

COO Pravin Rao says focus around digital; budget of $100-200 million

Half of all employees will be equipped with AI skills in 6-10 years: Microsoft

The combination of skilling and AI deployment is helping businesses succeed with 94% of senior executives from leading businesses already seeing value from AI deployment

India is the neglected elephant in TikTok’s room

TikTok’s salvage value appears to vary from place to place. Microsoft is in talks for the Chinese-owned short-video apps assets in the United States, Canada, Australia and New Zealand, while social ne

DocSumo raises $220k seed funding

Artificial Intelligence (AI) startup DocSumo has raised $220,000 in seed funding from early-stage venture firm Better Capital, TechStars and Barclays.The Mumbai-headquartered firm will use the funds t

E-commerce not just e-retail, new consumer rules must properly define digital products too

The govt must remove ambiguities from e-commerce definitions and liabilities & ensure there is harmony between Consumer Protection Rules, 2020 and other policies.

Immersive tech presents significant opportunity: Accenture’s Rekha Menon

Through our industry collaborations and alliances, we’re identifying new areas of application across sectors, and offering guidance, strategy, content and tools to deliver impactful XR-enabled experiences to our clients, globally

Hexaware Technologies Gets Shareholder Approval For Delisting

The information technology firm has received approval from a majority of its shareholders to delist from the exchanges.

India, Canada discuss ways to strengthen collaboration in science and technology

India News: NEW DELHI: India and Canada discussed ways to ramp up cooperation in science and technology by strengthening existing international connections, shari.

Infosys Foundation helps set up Covid-19 hospital in Bengaluru

A building meant for a BBMP hospital near Russell Market in Shivajinagar has now become a dedicated Covid-19 hospital, thanks to the Infosys Foundation. The foundation has spent Rs 10.25 crore to get the 170-bed hospital ready. The project, involving the import and shipping of medical equipment, took just 85 days to complete. The hospital is ready for inauguration.

India cannot grow well without honesty: NR Narayana Murthy

PE ratio is higher for companies committed to honesty transparency and intergrity, says the Infosys co-founder.

As Trump Fights China, Big Tech Savors Jio and India’s Promise

As user numbers at home plateau and U.S.-China tensions escalate, tech giants are looking more closely at India.

In India, the IT industry has created more opportunities for women than any other industry: Seema Ambastha, NTT-Netmagic

Hard work and dedication have helped Seema Ambasta, SVP - India & Global Business– NTT-Netmagic rise above many of her male counterparts over the course of the last 30 years and today she has a place in the company board. In an interview with Express Computer, she describes some of the key challenges that she has faced in her illustrious career, and how she has managed to carve her own niche in the competitive IT industry

Bullish on IT services, there is no competition for India: Vikas Khemani

On the supply side of IT services, it is only Indian. You cannot count more than 10-15 companies with the capability to cater to this demand.

TradeBriefs Publications are read by over 10,00,000 Industry Executives
About Us  |  Advertise Privacy Policy    

You are receiving this mail because of your subscription with TradeBriefs.
Our mailing address is GF 25/39, West Patel Nagar, New Delhi 110008, India